The base products of BIOTON S.A.
- recombinant human insulin in pharmaceutical substance form and as preparations for injections;
- oral hypoglycemic drug - glimepiride
Bioton WorldWide
Requires the Flash plugin. If the plugin is already installed, click here.
Members of the BIOTON Group
GPW
Press Contact
Contact for media:
Kinga Fromlewicz
Mobile: +48 506 025 066
Contact for investors:
Grzegorz Kubica